Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

BACKGROUND: When administered in the late follicular phase to prevent an LH surge, GnRH antagonists induce a sharp decrease in serum LH levels that may be detrimental for assisted reproductive technology cycle outcome. Therefore, a prospective study was designed to assess the effects of recombinant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human reproduction (Oxford) 2004-09, Vol.19 (9), p.1979-1984
Hauptverfasser:	Cédrin-Durnerin, I., Grange-Dujardin, D., Laffy, A., Parneix, I., Massin, N., Galey, J., Théron, L., Wolf, J.P., Conord, C., Clément, P., Jayot, S., Hugues, J.N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult assisted reproductive technology Biological and medical sciences Cell Count controlled ovarian stimulation Delivery, Obstetric - statistics & numerical data Embryo Implantation - drug effects Embryo, Mammalian - drug effects Embryology: invertebrates and vertebrates. Teratology Estradiol - blood Female Fertilization in Vitro Fundamental and applied biological sciences. Psychology GnRH antagonist Gonadotropin-Releasing Hormone - analogs & derivatives Gonadotropin-Releasing Hormone - antagonists & inhibitors Gonadotropin-Releasing Hormone - therapeutic use Hormone Antagonists - therapeutic use Humans Luteinizing Hormone - therapeutic use Oocytes - cytology Oocytes - drug effects Prospective Studies Recombinant Proteins - therapeutic use rLH Sperm Injections, Intracytoplasmic Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!